Table:
begin	end	state
1	29	signal peptide
30	313	non-cytoplasmic
314	336	transmembrane
337	347	cytoplasmic
348	369	transmembrane
370	374	non-cytoplasmic
375	395	transmembrane
396	442	cytoplasmic
443	456	transmembrane
457	472	cytoplasmic
473	494	transmembrane
495	515	non-cytoplasmic

Input:
>WP_012468821.1 NCBI__GCF_000020385.1:WP_012468821.1
MNKPMRVTSLLIYLAVLFLCTAAGGCNSNQLPTSGSRSMLATANDLQDKRIAVLQGSTHE
MYATRHYPGATVLQYKSVSDMLLALKSGKADAAIYSRDELMEYMRDNDEFGFVGGPLYRT
PISIAFHQQDAGLLLSFNRFLQQIRTDGTYDGMLKRWMQQGAVGMPKLTAAGTGKPLVVG
ILSDNGLPFIVMKENRLIGFNIELMERFGAFCNRSIKYADIEFGSQIAALAGHKIDMIAT
PLAITEERKKRVAFSAPYYTVDSLAFALKKNIATNKSLTPSAPSFLSKLVTSFQSNIIHE
RRYLLILDGLKTTVVISVFATLFGTLLGALICFMRMAKSRLLSAPARLYIAILRGTPVLV
LLMLIFYVVFASININPVIVAVIAFGMNFGAYTAEIFRTGIEGVEKGQTEAGISLGFTRT
STFLHIVLPQMVRRILPVYKGEFISLVKMTSIVGYIAVQDLTKASDIIRSRTFDAFFPLV
MVAILYFLISWTLMQSLEYLERITDPKYKKRKAGR

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server